Skip to main content
TipRanks
Go Ultimate75% OFF

Jennifer Simpson Insider Profile

4 Followers

Jennifer Simpson, President & CEO, Director at Panbela Therapeutics, holds 7.87K shares in Panbela Therapeutics (Ticker: PBLA), holds 25.00K shares in LadRx (Ticker: LADX), holds 25.02K shares in Delcath Systems (Ticker: DCTH).

Jennifer Simpson's Trading History

PBLA
Panbela Therapeutics
Feb 01, 2023President & CEO, DirectorUninformative Buy―$86.55
LADX
LadRx
Dec 17, 2021DirectorUninformative Buy―$275.00
DCTH
Delcath Systems
May 08, 2020President & CEO, DirectorUninformative Buy―$514.18K
EGRX
Eagle Pharmaceuticals
―Director――

You May Also Like

Jennifer Simpson insider profile FAQ

What is the percentage of profitable transactions made by Jennifer Simpson?
The percentage of profitable transactions made by Jennifer Simpson is 0%.
What is the average return per transaction made by Jennifer Simpson?
The average return per transaction made by Jennifer Simpson is -69.80%.
What stocks does Jennifer Simpson hold?
Jennifer Simpson holds: PBLA, LADX, DCTH, EGRX stocks.
What was Jennifer Simpson's most profitable transaction?
Jennifer Simpson’s most profitable transaction was an Informative Buy of PBLA stock on September 14, 2020. The return on the trade was -28.00%.
What is Jennifer Simpson's role in Panbela Therapeutics?
Jennifer Simpson's role in Panbela Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.